The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors

In this study, perioperative propranolol β-blockade was administered to patients with surgically resectable primary gastrointestinal tumors to explore the safety, efficacy, and alleviation of perioperative psychological stress. At the same time, a multi-omics study was conducted using clinical samples to explore the activation of anti-tumor immune response and its mechanism.

NCT Number	NCT06775080
Lead Sponsor	Huashan Hospital
Conditions	Gastrointestinal Tumors
Enrollment	40 participants
Start Date	2024-12-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-01-14